Lilly Receives European Marketing Authorization for tirzepatide in KwikPen® Presentation for Two Indications
Eli Lilly and Company announced that the European Commission (EC) granted marketing authorization (MA) on 19 April 2024 for tirzepatide (Mounjaro®) solution for injection in a multi-dose KwikPen®…
